These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 8296679)
1. Anti-MPO antibody (Id) and autoantibody to purified anti-MPO F(ab)2 (anti-Id). Zhao MH; Short A; Lockwood CM Adv Exp Med Biol; 1993; 336():77-80. PubMed ID: 8296679 [No Abstract] [Full Text] [Related]
2. Anti-idiotype antibodies to anti-myeloperoxidase autoantibodies in patients with systemic vasculitis. Jayne DR; Esnault VL; Lockwood CM J Autoimmun; 1993 Apr; 6(2):221-6. PubMed ID: 8388692 [TBL] [Abstract][Full Text] [Related]
3. Anti-idiotypic activity against anti-myeloperoxidase antibodies in pooled human immunoglobulin. Pall AA; Varagunam M; Adu D; Smith N; Richards NT; Taylor CM; Michael J Clin Exp Immunol; 1994 Feb; 95(2):257-62. PubMed ID: 8306501 [TBL] [Abstract][Full Text] [Related]
4. Pooled human IGG (PHIG) inhibits the binding of anti-myeloperoxidase antibodies to myeloperoxidase. Pall AA; Varagunam M; Adu D; Smith N; Taylor CM; Michael J Adv Exp Med Biol; 1993; 336():93-6. PubMed ID: 8296681 [TBL] [Abstract][Full Text] [Related]
5. Characterization of anti-myeloperoxidase antibodies in vasculitis. Tadros M; Pozzi C; Radice A; Sinico RA; D'Amico G Adv Exp Med Biol; 1993; 336():291-4. PubMed ID: 7507628 [TBL] [Abstract][Full Text] [Related]
6. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Savage CO; Pottinger BE; Gaskin G; Pusey CD; Pearson JD Am J Pathol; 1992 Aug; 141(2):335-42. PubMed ID: 1323218 [TBL] [Abstract][Full Text] [Related]
7. Anti-myeloperoxidase antibodies in patients with rheumatoid arthritis: prevalence, clinical correlates, and IgG subclass. Cambridge G; Williams M; Leaker B; Corbett M; Smith CR Ann Rheum Dis; 1994 Jan; 53(1):24-9. PubMed ID: 8311550 [TBL] [Abstract][Full Text] [Related]
8. Neutrophil and recombinant myeloperoxidase as antigens in ANCA positive systemic vasculitis. Short AK; Lockwood CM; Bollen A; Moguilevsky N Clin Exp Immunol; 1995 Oct; 102(1):106-11. PubMed ID: 7554375 [TBL] [Abstract][Full Text] [Related]
9. Anti-myeloperoxidase antibodies and associated diseases. Chevailler A; Subra JF; Renier G; Carrère F; Hurez D Adv Exp Med Biol; 1993; 336():263-6. PubMed ID: 8296616 [TBL] [Abstract][Full Text] [Related]
10. Identification of apparent dual ANCA specificities in a subset of patients with systemic vasculitis and crescentic glomerulonephritis. Teeraratkul P; Thorson JA; Kemp JD; Goeken JA Adv Exp Med Biol; 1993; 336():455-9. PubMed ID: 8296656 [TBL] [Abstract][Full Text] [Related]
11. Lactoferrin co-purifies with myeloperoxidase and is recognised by anti-neutrophil cytoplasm antibodies. Esnault VL; Short AK; Jones SJ; Skehel M; Walker J; Lockwood CM Adv Exp Med Biol; 1993; 336():101-4. PubMed ID: 8296596 [TBL] [Abstract][Full Text] [Related]
12. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis. Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929 [TBL] [Abstract][Full Text] [Related]
13. Perinuclear antineutrophil cytoplasmic antibodies (p-ANCA): clinical significance and relation to antibodies against myeloid lysosomal enzymes. Tervaert JW; Mulder AH; Kallenberg CG Adv Exp Med Biol; 1993; 336():253-6. PubMed ID: 8296614 [TBL] [Abstract][Full Text] [Related]
14. Detection of anti-myeloperoxidase antibodies in the serum of patients with type 1 diabetes mellitus. Accardo-Palumbo A; Triolo G; Giardina E; Carbone MC; Ferrante A; Triolo G Acta Diabetol; 1996 Jul; 33(2):103-7. PubMed ID: 8870810 [TBL] [Abstract][Full Text] [Related]
15. New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies. Jennette JC; Falk RJ Curr Opin Rheumatol; 2008 Jan; 20(1):55-60. PubMed ID: 18281858 [TBL] [Abstract][Full Text] [Related]
16. [The significances of peripheral neutrophils CD(55) and myeloperoxidase expression in patients with myeloperoxidase-specific anti-neutrophil cytoplasmic antibody associated vasculitis]. Zhou XL; Zheng MJ; Shuai ZW; Zhang L; Zhang MM; Chen SY Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):427-432. PubMed ID: 28592042 [No Abstract] [Full Text] [Related]
17. Significance of autoantibodies to purified proteinase 3 in systemic vasculitis. Gaskin G; Turner AN; Ryan JJ; Rees AJ; Pusey CD Adv Exp Med Biol; 1993; 336():287-9. PubMed ID: 8296619 [TBL] [Abstract][Full Text] [Related]
18. An IgM class anti-neutrophil cytoplasm antibody inhibits neutrophil adhesion and apoptosis via a Syk dependent signaling cascade. Hayes MJ; Cambridge G Mol Immunol; 2004 Jun; 41(4):457-68. PubMed ID: 15163542 [TBL] [Abstract][Full Text] [Related]
19. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis]. Zhang L; Shuai Z; Hu Z; Zhang M; Chen S Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012 [TBL] [Abstract][Full Text] [Related]
20. Clinical and pathological manifestations of patients with antineutrophil cytoplasmic autoantibodies directed against proteinase 3 or myeloperoxidase. Zhang X; Dong Y; Zeng X; Li Y; Tang F Chin Med Sci J; 2002 Mar; 17(1):32-5. PubMed ID: 12894882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]